"10.1371_journal.pmed.1001588","plos medicine","2014-02-04T00:00:00Z","Baiju R Shah; Onil Bhattacharyya; Catherine H Y Yu; Muhammad M Mamdani; Janet A Parsons; Sharon E Straus; Merrick Zwarenstein","University of Toronto, Toronto, Ontario, Canada; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada; Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada; Li Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada; University of Western Ontario, London, Ontario, Canada","Conceived and designed the experiments: BRS MZ. Performed the experiments: BRS MZ. Analyzed the data: BRS MZ. Wrote the first draft of the manuscript: BRS. Contributed to the writing of the manuscript: BRS OB CHYY MMM JAP SES MZ. ICMJE criteria for authorship read and met: BRS OB CHYY MMM JAP SES MZ. Agree with manuscript results and conclusions: BRS OB CHYY MMM JAP SES MZ.","BRS was a member of the Guideline Dissemination and Implementation Committee and the National Research Council of the Canadian Diabetes Association (CDA) at the time of the study. OB was a member of the Executive of the Clinical and Scientific Section and the Guideline Dissemination and Implementation Committee of the CDA at the time of the study. CHYY is currently Chair of the Guideline Dissemination and Implementation Committee of the CDA. MMM has served as an Advisory Board member for the following pharmaceutical companies: Astra Zeneca, Bristol-Myers Squibb, Eli Lilly and Company, Glaxo Smith Kline, Hoffman La Roche, Novartis, Novo Nordisk, and Pfizer. JAP has served as both a guest academic editor and a reviewer for PLOS Medicine.","2014","02","Baiju R Shah","BRS",7,TRUE,2,2,2,1,TRUE,TRUE,FALSE,0,NA,FALSE
